慢性丙型肝炎感染患者异基因造血干细胞移植后早期发生的进行性肝硬化 - Suppr

Suppr

超能文献

Progressive Hepatic Cirrhosis Early After Allogeneic Hematopoietic Stem Cell Transplantation in a Patient with Chronic Hepatitis C Infection.

作者信息

Kaito Satoshi, Doki Noriko, Hishima Tsunekazu, Takaki Yasunobu, Ohashi Kazuteru

机构信息

Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Hematology Division, Tokyo, Japan

Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Pathology Division, Tokyo, Japan

出版信息

Turk J Haematol. 2019 May 3;36(2):130-133. doi: 10.4274/tjh.galenos.2019.2018.0224. Epub 2019 Feb 5.

DOI:10.4274/tjh.galenos.2019.2018.0224

PMID:30717587

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6516096/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5710/6516096/350988405c91/TJH-36-130-g1.jpg

相似文献

Progressive Hepatic Cirrhosis Early After Allogeneic Hematopoietic Stem Cell Transplantation in a Patient with Chronic Hepatitis C Infection.慢性丙型肝炎感染患者异基因造血干细胞移植后早期发生的进行性肝硬化

Turk J Haematol. 2019 May 3;36(2):130-133. doi: 10.4274/tjh.galenos.2019.2018.0224. Epub 2019 Feb 5.

Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease.来迪派韦索磷布韦与利巴韦林联合治疗晚期肝病患者的 HCV 感染。

Gastroenterology. 2015 Sep;149(3):649-59. doi: 10.1053/j.gastro.2015.05.010. Epub 2015 May 15.

Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial.雷迪帕韦和索非布韦联合利巴韦林治疗基因型 1 或 4 型丙型肝炎病毒感染和晚期肝病患者：一项多中心、开放标签、随机、2 期临床试验。

Lancet Infect Dis. 2016 Jun;16(6):685-697. doi: 10.1016/S1473-3099(16)00052-9. Epub 2016 Feb 18.

Increased hepatic progenitor cell response and ductular reaction in patients with severe recurrent HCV post-liver transplantation.肝移植后严重复发性丙型肝炎病毒感染患者肝祖细胞反应增强及小胆管反应

Clin Transplant. 2016 Jun;30(6):722-30. doi: 10.1111/ctr.12740. Epub 2016 May 6.

Baseline Factors Associated With Improvements in Decompensated Cirrhosis After Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection.直接作用抗病毒治疗丙型肝炎病毒感染后失代偿期肝硬化改善的相关基线因素。

Gastroenterology. 2018 Jun;154(8):2111-2121.e8. doi: 10.1053/j.gastro.2018.03.022. Epub 2018 Mar 11.

Allogeneic hematopoietic cell transplantation for concurrent multiple myeloma and myelodysplastic syndrome.异基因造血细胞移植治疗同时性多发性骨髓瘤和骨髓增生异常综合征

Bone Marrow Transplant. 2015 Feb;50(2):296-7. doi: 10.1038/bmt.2014.233. Epub 2014 Oct 20.

Long-term treatment of chronic hepatitis C with ursodeoxycholic acid: influence of HCV genotypes and severity of liver disease.熊去氧胆酸对慢性丙型肝炎的长期治疗：HCV基因型及肝脏疾病严重程度的影响

Liver. 1999 Oct;19(5):381-8. doi: 10.1111/j.1478-3231.1999.tb00066.x.

Relationship between serum ferritin, hepatic iron staining, diabetes mellitus and fibrosis progression in patients with chronic hepatitis C.慢性丙型肝炎患者血清铁蛋白、肝脏铁染色、糖尿病与纤维化进展之间的关系

Aliment Pharmacol Ther. 2005 Mar 1;21(5):519-24. doi: 10.1111/j.1365-2036.2005.02382.x.

Regression of hepatic fibrosis in hepatitis C with long-term interferon treatment.长期干扰素治疗丙型肝炎中肝纤维化的消退

Dig Dis Sci. 1998 Dec;43(12):2573-6. doi: 10.1023/a:1026601904609.

Hepatitis C virus-associated fibrosing cholestatic hepatitis after renal transplantation: response to interferon-alpha therapy.肾移植后丙型肝炎病毒相关性纤维化淤胆型肝炎：对干扰素-α治疗的反应

Transplantation. 1998 Nov 15;66(9):1254-8. doi: 10.1097/00007890-199811150-00023.

本文引用的文献

Hepatitis C Virus Infection in Patients Undergoing Hematopoietic Cell Transplantation in the Era of Direct-Acting Antiviral Agents.直接抗病毒药物时代接受造血细胞移植患者的丙型肝炎病毒感染

Biol Blood Marrow Transplant. 2016 Apr;22(4):717-722. doi: 10.1016/j.bbmt.2015.12.010. Epub 2015 Dec 19.

Fibrosing cholestatic hepatitis C after hematopoietic cell transplantation: report of 3 fatal cases.造血细胞移植后纤维性胆汁淤积性丙型肝炎：3 例致死病例报告。

Am J Surg Pathol. 2015 Feb;39(2):212-20. doi: 10.1097/PAS.0000000000000345.

Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation.共病年龄指数：异基因造血细胞移植前生物学年龄的一种临床测量方法。

J Clin Oncol. 2014 Oct 10;32(29):3249-56. doi: 10.1200/JCO.2013.53.8157. Epub 2014 Aug 25.

Long-term follow-up of HCV-infected hematopoietic SCT patients and effects of antiviral therapy.慢性丙型肝炎病毒感染造血干细胞移植患者的长期随访和抗病毒治疗的效果。

Bone Marrow Transplant. 2012 Sep;47(9):1217-21. doi: 10.1038/bmt.2011.238. Epub 2011 Dec 12.

Clinical characterization of patients developing histologically-proven fibrosing cholestatic hepatitis C post-liver transplantation.肝移植后经组织学证实存在纤维性胆汁淤积性丙型肝炎患者的临床特征。

Hepatol Res. 2011 Apr;41(4):328-39. doi: 10.1111/j.1872-034X.2011.00781.x.

Allogeneic hematopoietic cell transplant in HCV-infected patients.丙型肝炎病毒感染患者的异基因造血细胞移植

J Hepatol. 2008 Jun;48(6):1008-17. doi: 10.1016/j.jhep.2008.03.003. Epub 2008 Apr 1.

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT.造血细胞移植（HCT）特异性合并症指数：一种用于异基因造血细胞移植前风险评估的新工具。

Blood. 2005 Oct 15;106(8):2912-9. doi: 10.1182/blood-2005-05-2004. Epub 2005 Jun 30.

Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C.通过测量慢性丙型肝炎患者的肝脏硬度进行肝纤维化的无创评估。

Hepatology. 2005 Jan;41(1):48-54. doi: 10.1002/hep.20506.

Long-term outcome of hepatitis C infection after bone marrow transplantation.骨髓移植后丙型肝炎感染的长期预后。

Blood. 2004 Mar 1;103(5):1618-24. doi: 10.1182/blood-2003-06-2145. Epub 2003 Oct 23.

Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection.丙型肝炎病毒感染的肾移植受者中的纤维化胆汁淤积性肝炎

Liver Transpl Surg. 1999 Jul;5(4):294-300. doi: 10.1002/lt.500050417.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验